Characteristics of computed tomography imaging of gastrointestinal stromal tumor (GIST) and related diagnostic problems.

OA: gold
📄 Open PDF Full text JSON View on PubMed
AI-generated summary by qwen3.7-flash, 2026-09-02

This paper outlines characteristic computed tomography imaging features of gastrointestinal stromal tumors that cause diagnostic difficulties, noting that RECIST size-based criteria are inadequate for monitoring treatment response to modern molecular targeted therapies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-09-02 · read from full text

This paper examines the diagnostic challenges associated with gastrointestinal stromal tumors (GIST), emphasizing the need for radiologists to possess specialized knowledge and training in centers dedicated to GIST treatment. It highlights the critical importance of communication between clinicians and radiologists regarding specific drug mechanisms, treatment durations, and any interruptions to therapy, as missing this information can lead to fatal misinterpretations of CT imaging results. Furthermore, the authors argue that traditional criteria based solely on tumor dimension measurements are insufficient due to new response patterns in targeted molecular therapy, necessitating updated evaluation standards. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

In this article, authors presented several characteristic features of Gastrointestinal Stromal Tumors (GISTs), which may lead to diagnostic errors and unexpected difficulties during interpretation of CT images. In case of GIST, one may encounter problems at every level of diagnostics and treatment response monitoring, especially after introduction of modern molecular targeting therapies. RECIST scale criteria, used until now for evaluation of response to treatment in solid tumors are based merely on the size of the tumor and turned out to be inadequate after introduction of treatment with new molecular target drugs such as Imatinib.
Full text 1,040 characters · extracted from pmc-nxml · 1 sections · click to expand

Conclusions

The variety of problems that arise in diagnostics and treatment monitoring of GIST tumors requires a thorough knowledge of this disease on the part of the reporting radiologist; optimally, provided by training in centers specializing in the treatment of GIST. Also, the importance of the flow of information between clinicians and radiologists evaluating effectiveness of chemotherapy increases. Radiologists have to possess information on the type of drug the patient receives, its mechanism of action and duration of treatment. They also must know whether there were interruptions in treatment and if so, when it was discontinued. Lack of this information may result in incorrect interpretation of changes seen in radiological studies and have fatal consequences for the patient. Due to the appearance of new patterns of therapeutic response in targeted molecular therapy and unique patterns of neoplastic progression, the criteria for radiological evaluation using CT that are based on measurements of tumor dimensions should be changed.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-13T09:25:22.628771+00:00